Jietao Lin

6PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Clinical Study on the Prevention of High-Risk Pulmonary Nodule Progression With Yifei Sanjie Pill: Protocol for a Multicenter Randomized Controlled Trial.

|May 17, 2025
External Application of a Xiaozhen zhiyang Decoction for Facial Rash Related to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Chinese Patients: A Prospective Single-Arm Observational Study.

Jietao Lin, Lingling Sun, Jing Zhang

|Jul 26, 2023
Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort).

Jietao Lin, Lingling Sun, Hanrui Chen

|Jan 30, 2023
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study.

Wenmin Chen, Jietao Lin, Ting Yang

|Oct 07, 2022
The Prognostic Value of Serum Apolipoprotein A-I Level and Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer Liver Metastasis.

Chongkai Fang, Yue Huang, Chuyao Chen

|Jan 18, 2020
Efficacy and safety of Jianpishengsui for chemotherapy-related fatigue in patients with non-small cell lung cancer: study protocol for a randomized placebo-controlled clinical trial.

Zhiwei Xiao, Leihao Hu, Jietao Lin

Pageof 1

Frequent Collaborators

3 joint publications

Lizhu Lin

2 joint publications

Zhiwei Xiao

2 joint publications

Lingling Sun

2 joint publications

Xiangjun Qi